Answers are grounded in this paper and cite their sources.
Coronavirus Disease-2019 (COVID-19), in its second wave, is infecting the young children and newborns too. Increasing number of pregnant women with COVID-19 is being reported globally, and the potential for vertical transmission of Severe Acute Respiratory Syndrome- Coronavirus-2 (SARS-CoV-2), either in-utero, intrapartum or in the early postnatal period is of concern. At present, the extent to which SARS-CoV-2 vertical transmission occurs, and timing of such transmission is unclear. This report describes the clinical course and laboratory findings in a neonate in whom SARS-CoV2 infection most likely occurred via vertical transmission. As the baby developed audible grunting and tachypnoea, 10 minutes after birth, all the relevant laboratory investigations were done. The chest X-ray showed bilateral lung opacities. The neonate developed signs and symptoms of severe COVID-19 pneumonia on day 1 of life, completely manifesting within few hours of birth. The nasopharyngeal swab was sent for Reverse Transcriptase- Polymerase Chain Reaction (RT-PCR) for SARS-CoV 2 after two days of birth. The RT-PCR test came out positive. With all other causes been ruled out and contributory laboratory findings (raised D-Dimer, lactate dehydrogenase and erythrocyte sedimentation rate) it can positively be labelled as a case of vertically transmitted intrauterine COVID-19 pneumonia in a newborn. The baby was treated with ventilator support, antibiotics and Low Molecular Weight Heparin (LMWH), and finally discharged after nine days of life and management at the hospital.
No takes yet. Share an insight, caveat, or question.
Hajela et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: